2019’s Most Popular Cancer Currents Blog Posts (so far)

Having trouble viewing this email? View it as a Web page.

With the end of summer in sight, we took a look back at the Cancer Currents posts published in the first half of 2019 to see what most piqued our readers' interest.   Once again, and perhaps not surprisingly, immunotherapy continues to be a topic of intense interest, but it is far from the only topic that caught readers' attention.   So, in case you missed them when they were first published or want to read them again or share them with a friend, here are some of our most-read posts of 2019.   Thank you for your interest in and support of Cancer Currents. We hope you'll continue to read the blog and encourage others to subscribe.   The Cancer Currents editorial team New Drugs, New Side Effects: Complications of Cancer Immunotherapy 05/10/2019 The expanding use of cancer immunotherapy has revealed a variety of side effects associated with this treatment approach. Researchers are now trying to better understand how and why these side effects occur and develop strategies for better managing them. Could a Vaccine Prevent Colorectal Cancer in People with Lynch Syndrome? 04/19/2019 Findings from an NCI-funded study suggest a new vaccine approach may have the potential to prevent colorectal cancer in people with Lynch syndrome, an inherited condition that increases an individual's risk for developing certain types of cancer. Glioblastoma Study Highlights Sex Differences in Brain Cancer 01/30/2019 Men and women with glioblastoma appear to respond differently to standard treatment. A new study identifies biological factors that might contribute to this sex difference. A CAR T-Cell Therapy for Multiple Childhood Cancers? 02/14/2019 An experimental CAR T-cell therapy may have potential as a treatment for several types of childhood cancer, results from a new study in mice suggest. The CAR T cells eradicated tumors in mouse models of several different childhood cancers, including two forms of sarcoma and medulloblastoma. Managing Cancer Pain: Are Better Approaches on the Horizon? 01/23/2019 Pain is a common and much-feared symptom among people with cancer and long-term survivors. As more people survive cancer for longer periods, there is a renewed interest in developing new, nonaddictive approaches for managing their chronic pain.

 

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp       Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

 

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892